Hepatitis C virus infection and cardiomyopathies.
Matsumori
Akira
A
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D009320:Atrial Natriuretic Factor / Q000096:biosynthesis / Q000235:genetics; D009202:Cardiomyopathies / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology / Q000821:virology; D015967:Gene Expression Regulation, Viral; D006681:HLA-D Antigens / Q000276:immunology; D006321:Heart / Q000821:virology; D006333:Heart Failure / Q000453:epidemiology / Q000209:etiology / Q000821:virology; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity / Q000502:physiology*; D006526:Hepatitis C / Q000150:complications* / Q000453:epidemiology; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D051379:Mice; D008822:Mice, Transgenic; D009205:Myocarditis / Q000150:complications* / Q000276:immunology / Q000821:virology; D009206:Myocardium / Q000737:chemistry / Q000473:pathology; D016328:NF-kappa B / Q000032:analysis; D020097:Natriuretic Peptide, Brain / Q000096:biosynthesis / Q000235:genetics; D016612:Paraffin Embedding; D010641:Phenotype; D015995:Prevalence; D012367:RNA, Viral / Q000032:analysis; D013045:Species Specificity; D018808:Transcription Factor AP-1 / Q000378:metabolism; D014758:Viral Core Proteins / Q000235:genetics / Q000502:physiology
D000998:Antiviral Agents; D006681:HLA-D Antigens; D018937:Hepatitis C Antibodies; D016328:NF-kappa B; D012367:RNA, Viral; D018808:Transcription Factor AP-1; D014758:Viral Core Proteins; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor; D007372:Interferons